Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jun 9, 2020
Date Accepted: Nov 10, 2020
Date Submitted to PubMed: Aug 4, 2020

The final, peer-reviewed published version of this preprint can be found here:

Metabolic Syndrome Parameters, Determinants, and Biomarkers in Adult Survivors of Childhood Cancer: Protocol for the Dutch Childhood Cancer Survivor Study on Metabolic Syndrome (Dutch LATER METS)

Pluimakers V, Fiocco M, Van Atteveld J, Hobbelink M, Bresters D, Van Dulmen-den Broeder E, Van der Heiden-van der Loo M, Janssens G, Kremer L, Loonen J, Louwerens M, Van der Pal H, Ronckers C, Van Santen H, Versluijs B, De Vries A, Van den Heuvel-Eibrink M, Neggers S

Metabolic Syndrome Parameters, Determinants, and Biomarkers in Adult Survivors of Childhood Cancer: Protocol for the Dutch Childhood Cancer Survivor Study on Metabolic Syndrome (Dutch LATER METS)

JMIR Res Protoc 2021;10(1):e21256

DOI: 10.2196/21256

PMID: 32750002

PMCID: 7875697

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Metabolic syndrome parameters, determinants, and biomarkers in adult survivors of childhood cancer: methodology of the Dutch Childhood Cancer Survivor Study Metabolic Syndrome (Dutch LATER METS Study)

  • Vincent Pluimakers; 
  • Marta Fiocco; 
  • Jenneke Van Atteveld; 
  • Monique Hobbelink; 
  • Dorine Bresters; 
  • Eline Van Dulmen-den Broeder; 
  • Margriet Van der Heiden-van der Loo; 
  • Geert Janssens; 
  • Leontien Kremer; 
  • Jacqueline Loonen; 
  • Marloes Louwerens; 
  • Heleen Van der Pal; 
  • Ceciel Ronckers; 
  • Hanneke Van Santen; 
  • Birgitta Versluijs; 
  • Andrica De Vries; 
  • Marry Van den Heuvel-Eibrink; 
  • Sebastian Neggers

ABSTRACT

Background:

Potential long-term effects of treatment for childhood cancer include adiposity, insulin resistance, dyslipidemia and hypertension. These risk factors cluster together as metabolic syndrome (MetS) and increase the risk for development of diabetes mellitus and cardio- and cerebrovascular disease. Knowledge on risk factors, timely diagnosis and preventive strategies is of importance to prevent cardio- and cerebrovascular complications and improve quality of life. Currently, no studies in national cohorts on prevalence and determinants of MetS in childhood cancer survivors including biomarkers and genetic predisposition are available.

Objective:

Describe the methodology of the Dutch LATER METS study on prevalence and risk factors of metabolic syndrome in adult survivors of childhood cancer, treated between 1963 and 2002.

Methods:

The current study is a cross-sectional study, based on recruitment of a national cohort of adult long-term survivors, that will assess 1) prevalence as well as disease- and treatment-related and genetic risk factors of MetS and its separate components, compared to available normative data, and 2) diagnostic value of biomarkers. Metabolic syndrome will be classified according to the definitions of the National Cholesterol Education Program (NCEP-ATPIII) as well as the International Diabetes Federation (IDF), and DXA-scans will be performed to assess body composition in more detail. A total of 2380 survivors was included, between 2016 and 2020, in seven pediatric oncology hospitals.

Results:

n.a.

Conclusions:

The Dutch LATER METS study will provide knowledge on clinical and genetic determinants of MetS, and the diagnostic value of biomarkers, in survivors. The results of this study will be used to optimize surveillance guidelines for MetS in survivors, and improve follow-up of survivors.


 Citation

Please cite as:

Pluimakers V, Fiocco M, Van Atteveld J, Hobbelink M, Bresters D, Van Dulmen-den Broeder E, Van der Heiden-van der Loo M, Janssens G, Kremer L, Loonen J, Louwerens M, Van der Pal H, Ronckers C, Van Santen H, Versluijs B, De Vries A, Van den Heuvel-Eibrink M, Neggers S

Metabolic Syndrome Parameters, Determinants, and Biomarkers in Adult Survivors of Childhood Cancer: Protocol for the Dutch Childhood Cancer Survivor Study on Metabolic Syndrome (Dutch LATER METS)

JMIR Res Protoc 2021;10(1):e21256

DOI: 10.2196/21256

PMID: 32750002

PMCID: 7875697

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.